Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

---
Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026
Vote:
0 0
Previous Origin Agritech to Hold Business Update & Fiscal Year 2025 Earnings Conference Call on Monday, February 2 at 8 a.m. ET
Next Farmmi, Inc. Establishes New U.S. Subsidiary to Focus on Digital Marketing Business

Related News

'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week

SanegeneBio Announces RNAi Licensing and Research Collaboration with Lilly

Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023

Syneron Bio Announces Strategic Collaboration with AstraZeneca

Athos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063

Accropeutics Secured $12 Million in Series B Plus Financing

menu
menu